Biopharma
Abstract — The biopharmaceutical industry stands at a crossroads, defined by two distinct and powerful models of research and development. The United States, with its deep scientific roots and massive capital markets, has long been the…
Leadership
Egypt is emerging as a premier destination for medical and dental tourism, driven by its blend of competitive pricing, advanced cosmetic dentistry, and rich cultural heritage. Beyond its historic landmarks, the country is gaining recognition for…
Biopharma
MENA & Türkiye Biopharma and Pharmaceutical Industry | Executive Industry Perspective Coverage: 2026 The Middle East pharmaceutical industry is entering a new phase. The strategic question is no longer simply who manufactures the largest number of…
Biopharma
Saudi Healthcare Listed Market | August 2026 August 2026 has been an important month for Saudi Arabia’s listed healthcare market. Financial results, operational developments and new contracts announced during the month provide valuable insight into the…
Biopharma
A roundup of key developments in the Saudi listed healthcare sector for the month of August 2026. 📰 1. Avalon Pharma Signs Major Biosimilar Deal Middle East Pharmaceutical Industries Co. (Avalon Pharma) announced a strategic agreement…
Business of Health
Elevate Capital & Moharram Family Acquire Nile Scan and Labs in EGP 1bn Deal July 21, 2026 · Cairo, Egypt In a move that could redefine private diagnostic services in Egypt, Elevate Capital and the Moharram…
Industry Brief
A $400M pharmaceutical complex east of Cairo aims to reduce MENA dependence on imported generics by 35% within five years.
Chat with us
We typically reply within a few hours during business days.
